Headache Medicine Fellowship

The 2026 Headache Medicine Fellowship – US is a competitive grant opportunity administered by Pfizer through its established Competitive Grant Program. This initiative is designed to support U.S.-based academic institutions offering clinical training in headache medicine. The program prioritizes institutions located in regions with persistent healthcare workforce shortages and emphasizes the importance of diversity and inclusion in clinical education. Pfizer aims to fund fellowship programs that not only offer robust clinical training and independent research opportunities but also demonstrate a commitment to mentoring, education, and the advancement of patient outcomes in headache medicine. Eligible applicants are accredited academic institutions within the United States that can demonstrate the capacity to support a one-year fellowship in headache medicine. These institutions must have strong mentoring capabilities, research training infrastructure, and a program structure that does not involve or benefit Pfizer’s business or any of its products. The grant is strictly institutional; individual fellows are not eligible to apply directly. Institutions are encouraged to structure their programs around underserved geographic areas and populations, and proposals addressing healthcare disparities and social determinants of health will receive preference. The fellowship supports one physician fellow (MD or DO), who must be a U.S. worker or hold appropriate employment authorization. Applicants must intend to pursue United Council for Neurologic Subspecialties (UCNS) certification in headache medicine or may come from related specialties like primary care, emergency medicine, or obstetrics and gynecology. Clinical training is optional but permissible as long as activities supported by the grant are not billed as patient care. Grant funds are limited to supporting salary and benefits; indirect costs and overhead are not permitted. Applications must be submitted through the CyberGrants portal dedicated to Pfizer’s Global Medical Grants Fellowships. The process requires applicants to complete all sections of the online form and upload their proposal using the designated template. Proposals must outline the fellowship’s goals, methods, mentoring structure, available resources, anticipated challenges, and timeline. The submission deadline is April 6, 2026, at 11:59 PM Eastern Time. Late submissions will not be reviewed under any circumstances. Proposals will undergo a thorough review by an expert review panel composed of professionals from the medical and academic community. Evaluation criteria include the quality and clarity of the fellowship’s goals and objectives, population health focus, clinical experience opportunities, mentorship and training models, and institutional resources. Notification of award decisions is anticipated in May 2026, with projects expected to start in June 2026 or later. Each award will support a one-year fellowship with funding capped at $90,000. The fellowship duration is expected to conclude around June 2027. For questions related to the RFP, applicants are encouraged to contact Grant Officer Sue Lee via email at [email protected], using the subject line “2026 IM US Headache Medicine Fellowship.” Further information about the submission process and frequently asked questions can be found on the CyberGrants portal. This opportunity represents Pfizer’s ongoing commitment to independent research, clinical training, and improving access to care in underserved areas through targeted educational support.

Emphasize underserved geography, healthcare disparities, and DEI strategies; avoid any content that implies Pfizer product benefit.